Literature DB >> 15722342

EphB receptor-binding peptides identified by phage display enable design of an antagonist with ephrin-like affinity.

Mitchell Koolpe1, Rosemary Burgess, Monique Dail, Elena B Pasquale.   

Abstract

The Eph receptor tyrosine kinases are overexpressed in many pathologic tissues and have therefore emerged as promising drug target candidates. However, there are few molecules available that can selectively bind to a single Eph receptor and not other members of this large receptor family. Here we report the identification by phage display of peptides that bind selectively to different receptors of the EphB class, including EphB1, EphB2, and EphB4. Peptides with the same EphB receptor specificity compete with each other for binding, suggesting that they have partially overlapping binding sites. In addition, several of the peptides contain amino acid motifs found in the G-H loop of the ephrin-B ligands, which is the region that mediates high-affinity interaction with the EphB receptors. Consistent with targeting the ephrin-binding site, the higher affinity peptides antagonize ephrin binding to the EphB receptors. We also designed an optimized EphB4-binding peptide with affinity comparable with that of the natural ligand, ephrin-B2. These peptides should be useful as selective inhibitors of the pathological activities of EphB receptors and as targeting agents for imaging probes and therapeutic drugs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15722342     DOI: 10.1074/jbc.M500363200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

Review 1.  Targeting Eph receptors with peptides and small molecules: progress and challenges.

Authors:  Roberta Noberini; Ilaria Lamberto; Elena B Pasquale
Journal:  Semin Cell Dev Biol       Date:  2011-10-25       Impact factor: 7.727

2.  Endothelial cells regulate cardiomyocyte development from embryonic stem cells.

Authors:  Kang Chen; Hao Bai; Melanie Arzigian; Yong-Xing Gao; Jing Bao; Wen-Shu Wu; Wei-Feng Shen; Liqun Wu; Zack Z Wang
Journal:  J Cell Biochem       Date:  2010-09-01       Impact factor: 4.429

Review 3.  Eph receptors and ephrins in cancer: bidirectional signalling and beyond.

Authors:  Elena B Pasquale
Journal:  Nat Rev Cancer       Date:  2010-03       Impact factor: 60.716

4.  Involvement of EphB/Ephrin-B signaling in axonal survival in mouse experimental glaucoma.

Authors:  Christine T Fu; David Sretavan
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-05       Impact factor: 4.799

5.  EphB2 and EphB4 receptors forward signaling promotes SDF-1-induced endothelial cell chemotaxis and branching remodeling.

Authors:  Ombretta Salvucci; Maria de la Luz Sierra; Jose A Martina; Peter J McCormick; Giovanna Tosato
Journal:  Blood       Date:  2006-07-13       Impact factor: 22.113

6.  Three-dimensional structure of the EphB2 receptor in complex with an antagonistic peptide reveals a novel mode of inhibition.

Authors:  Jill E Chrencik; Alexei Brooun; Michael I Recht; George Nicola; Leila K Davis; Ruben Abagyan; Hans Widmer; Elena B Pasquale; Peter Kuhn
Journal:  J Biol Chem       Date:  2007-09-26       Impact factor: 5.157

7.  Structure of the ligand-binding domain of the EphB2 receptor at 2 A resolution.

Authors:  Yehuda Goldgur; Sari Paavilainen; Dimitar Nikolov; J P Himanen
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-01-31

8.  EphrinB reverse signaling contributes to endothelial and mural cell assembly into vascular structures.

Authors:  Ombretta Salvucci; Dragan Maric; Matina Economopoulou; Shuhei Sakakibara; Simone Merlin; Antonia Follenzi; Giovanna Tosato
Journal:  Blood       Date:  2009-05-01       Impact factor: 22.113

9.  Small molecules can selectively inhibit ephrin binding to the EphA4 and EphA2 receptors.

Authors:  Roberta Noberini; Mitchell Koolpe; Satyamaheshwar Peddibhotla; Russell Dahl; Ying Su; Nicholas D P Cosford; Gregory P Roth; Elena B Pasquale
Journal:  J Biol Chem       Date:  2008-08-26       Impact factor: 5.157

10.  Design, synthesis and characterization of novel small molecular inhibitors of ephrin-B2 binding to EphB4.

Authors:  Srinivas Duggineni; Sayantan Mitra; Roberta Noberini; Xiaofeng Han; Nan Lin; Yan Xu; Wang Tian; Jing An; Elena B Pasquale; Ziwei Huang
Journal:  Biochem Pharmacol       Date:  2012-12-17       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.